Prous Institute Presents the Prous Institute – Overton & Meyer Award for New Technologies in Drug Discovery to Prof Gisbert Schneider

Prous Institute Presents the Prous Institute – Overton & Meyer Award for New Technologies in Drug Discovery to Prof Gisbert Schneider

Prous Institute for Biomedical Research is to present the 2020 Prous Institute – Overton & Meyer
Award to Professor Gisbert Schneider, at the XXVI International Symposium on Medicinal Chemistry
organized by the European Federation of Medicinal Chemistry (EFMC).

The award, conferred every two years, recognizes outstanding contributions to the development of
new technologies in the field of medicinal chemistry and acknowledges the awardee’s contribution to
the discovery and development of innovative technologies that advance the field.

Prof Schneider has pioneered the integration of machine learning into medicinal chemistry, drug
discovery and chemical biology. His contributions spread across the whole drug discovery process
and introduced visionary concepts for concrete applications of computational methods. These are
now broadly adopted in drug discovery and recognized as robust foundations for transformative
advancements in the field.

Prof Schneider is Full Professor at ETH Zurich, holding the chair of Computer-Assisted Drug Design
and Director of Singapore – ETH Centre.

The award will be presented during the XXVI International Symposium on Medicinal Chemistry
(EFMC-ISMC 2021), to be held on August 29 – September 2, 2021. The Award plenary Lecture is
scheduled for Sunday, August 29 at 14:00 CET.

 

About the Prous Institute for Biomedical Research

Prous Institute for Biomedical Research, created as a spin-off of Prous Science (acquired by
Thomson Reuters, now Clarivate Analytics, in 2007) is committed to supporting the discovery of
novel therapeutic and diagnostic approaches.

Originally founded by Dr. J.R. Prous, Prous Institute has evolved to expand its mission beyond its
own developments by partnering and investing in transformative science initiatives.

By leveraging more than 60 years’ experience in the life sciences, we offer the resources and
capabilities needed by researchers to move their research closer to the patient bedside.

 

About the European Federation of Medicinal Chemistry (EFMC)

The EFMC is an independent association representing medicinal chemistry societies in Europe. Its
objective is to advance the science of medicinal chemistry by promoting cooperation and networking,
by providing training and mentoring, by rewarding scientific excellence, and by facilitating
communication and influencing stakeholders.